ClinicalTrials.gov
public full text
Public Domain
An Interaction Study of LY3200882 in Healthy Participants
The main purpose of this study is to evaluate the effect of itraconazole on the amount of LY3200882 in the blood stream and how long the body takes to get rid of LY3200882. The safety and tolerability of LY3200882 when given with itraconazole will be evaluated. The study is expected to last up to 19 days from the first dose to follow-up (inclusive). Screening will occur up to 28 days prior to enrollment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3337641 in Japanese and Caucasian Healthy Participants#1339892
- A Safety Study of LY3372689 in Healthy Participants#1172415
- Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants#969660
- A Study of LY3463251 in Healthy Participants#906560
- A Study of LY3832479 (LY-CoV016) in Healthy Participants#1152266
Record · ID 1376302
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive